A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke

Increased Risk of Adverse Pregnancy Outcomes in Women Receiving Zolpidem During Pregnancy

(2010) L-H Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis

(2010) A. John Camm   CLINICAL THERAPEUTICS

Reflux Esophagitis and the Risk of Stroke in Young Adults

(2010) Jau-Jiuan Sheu et al.   STROKE

No increase in adverse pregnancy outcomes for women receiving antiepileptic drugs

(2009) Hsiu-Li Lin et al.   JOURNAL OF NEUROLOGY

The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis

(2009) Murat Celiloglu et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy

(2009) Robert S. Weinstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physician's Case Volume of Intensive Care Unit Pneumonia Admissions and In-Hospital Mortality

(2008) Herng-Ching Lin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Effect of Smoking in Midlife on Health-Related Quality of Life in Old Age

(2008) Arto Y. Strandberg et al.   ARCHIVES OF INTERNAL MEDICINE

Use of Alendronate and Risk of Incident Atrial Fibrillation in Women

(2008) Susan R. Heckbert et al.   ARCHIVES OF INTERNAL MEDICINE

Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells

(2008) Liang Wu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

(2008) P. Anagnostis et al.   OSTEOPOROSIS INTERNATIONAL